Author profile
Howard Feldman, MD, FRCPC
Alzheimer disease (AD) is a syndrome with cognitive, functional, and behavioral aspects that significantly affect patients, family members and professional caregivers over the long term. Home care is often followed by... Read More
In the September issue of this journal, several articles reviewed and endorsed the use of cholinesterase inhibitors in the treatment of Alzheimer disease. These included a report of a consensus conference (TREAD)[1]... Read More
It has been almost a century since Dr Alois Alzheimer first described his patient, a 51-year-old woman who had such unusual symptoms that she could not be diagnosed with any known disease. The careful clinical... Read More
The traditional view of dementia experienced in later life has focused on a unitary disease causation, most often Alzheimer disease (AD). Traditional teaching has led to the diagnosis of AD through excluding items in a... Read More